Literature DB >> 6840388

Histopathologic evaluation of response to treatment of human tumors grown in the nude mouse.

A A Kyriazis, A P Kyriazis, J G Kereiakes, M S Soloway, W B McCombs.   

Abstract

The histopathologic changes following chemotherapy treatment of a number of human tumors grown in nude mice were evaluated. On the basis of the histopathologic profile, three response levels were recognized--a mild response, a moderate response and a severe response. Severe response was characterized by arrest of cell division and profound nuclear-cytoplasmic degenerative changes. Regrowth of effectively treated tumors originated in clusters of cells most probably representing resistant tumor cell clones. Histopathologic changes represent a sensitive indicator of the response of nude mouse grown human tumors to anticancer agents. Availability and correct interpretation of the post-treatment histopathologic picture is of importance in selecting the proper combination treatment which would maximize tumor response.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6840388     DOI: 10.1159/000163178

Source DB:  PubMed          Journal:  Exp Cell Biol        ISSN: 0304-3568


  4 in total

1.  Experimental studies of chemosensitivity testing of urothelial cancer grown in nude mice.

Authors:  A P Kyriazis; A A Kryiazis; A Yagoda
Journal:  Urol Res       Date:  1990

2.  Histologic and ultrastructural alterations of a xenografted human colon adenocarcinoma after treatment with titanocene dichloride.

Authors:  P Köpf-Maier
Journal:  J Cancer Res Clin Oncol       Date:  1988       Impact factor: 4.553

3.  Vinblastine and 5-fluorouracil sensitivity of xenografts of four pancreatic ductal adenocarcinomas: is there a correlation with histological and cytological tumour differentiation?

Authors:  A Vergeylen; G Klöppel
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

4.  The oncogenic role of the cerebral endothelial cell adhesion molecule (CERCAM) in bladder cancer cells in vitro and in vivo.

Authors:  Yali Zuo; Xiaoliang Xu; Minfeng Chen; Lin Qi
Journal:  Cancer Med       Date:  2021-06-08       Impact factor: 4.452

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.